Q-Line Biotech Ltd. makes a strong debut on the bourses with scrip got listed at Rs 452.00 on the Bombay Stock Exchange, a 31.77 per cent premium to its issue price of Rs 343.00. On the National Stock Exchange, the stock was listed at Rs 452.00.

The company, which raised 0.63 Cr from initial public offering, was subscribed 0 times, receiving bids for 0 lakhs shares against the total issue size of 62.53 lakhs shares.

The company, listed under ST Group Securities post its IPO, opened for subscription from May 21 to May 25.

Following a strong opening, the scrip touched an intraday high of Rs 474.60 and a low of Rs 431.00, before closing the session up by 38.36 per cent to its listing price at Rs 474.60 on the NSE.

The company anticipates using the proceeds of the issue for .

Hem Securities Ltd,Share India Capital Services Pvt. Ltd. as lead managers & Purva Sharegistry (India) Pvt. Ltd. is the registrar, to the issue.

Meanwhile, the broader benchmark NSE Nifty closed trade at 23,547.75, down 359.40 points, or 1.50 per cent.